Journal article
Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study
Abstract
In this prospective cohort of 6120 participants aged 50+, nitrogen-bisphosphonates but not non-nitrogen bisphosphonates were associated with a significant 34% mortality risk reduction compared to non-treated propensity score matched controls. These findings open new avenues for research into mechanistic pathways.IntroductionEmerging evidence suggests that bisphosphonates (BP), first-line treatment of osteoporosis, are associated with reduced …
Authors
Bliuc D; Tran T; van Geel T; Adachi JD; Berger C; van den Bergh J; Eisman JA; Geusens P; Goltzman D; Hanley DA
Journal
Osteoporosis International, Vol. 30, No. 4, pp. 817–828
Publisher
Springer Nature
Publication Date
4 2019
DOI
10.1007/s00198-018-4806-0
ISSN
0937-941X